私募MOM新增备案按下“暂停键”！什么原因？

Core Viewpoint - The article discusses the recent developments in the private equity MOM (Manager of Managers) products, particularly in the context of insurance capital's interest and regulatory concerns regarding potential "channelization" of these products [1][2]. Group 1: Regulatory Environment - Insurance capital has shown a preference for quantitative private equity funds due to their relatively stable performance amid a warming stock market and regulatory encouragement for long-term capital investment [1]. - The China Securities Investment Fund Industry Association has not recorded any new MOM product registrations since September 2, 2025, indicating a regulatory pause on new filings [2]. - Concerns from regulators focus on the potential for MOM products to deviate from active management and become mere channels for investment, which contradicts the current regulatory direction aimed at reducing channelized business models [2][3]. Group 2: MOM Product Development - The number of registered private equity MOM products surged to a historical high in 2025, with 58 new registrations, more than double the 23 registered in 2024 [4]. - The growth in MOM product registrations is primarily driven by the influx of bank wealth management and insurance funds, which prefer the flexible strategies and risk diversification offered by quantitative private equity [5]. - Nearly 60% of the newly registered MOM products in 2025 were structured as single asset management plans, reflecting the involvement of various institutional investors like banks and insurance companies [6]. Group 3: Market Dynamics and Future Outlook - Broker asset management firms have emerged as key players in the MOM product space, with five firms collectively registering 39 products, accounting for 67% of the total [7]. - The performance of Huaxin Securities, which registered 30 products, is attributed to its long-term resource accumulation in the quantitative private equity sector [7]. - Despite the current regulatory pause, industry insiders anticipate that the suspension may be temporary, with expectations for future policy clarifications that could reopen the market for MOM products [7][8].